Overview
Insider activity this period was led by significant selling in healthcare and biotechnology, while notable buying was concentrated in communication services and select financials.
High Signal
LILA — Angoitia Alfonso de (indirect — By Grenadier S.A.) purchased $9.98M across 3 filings between 2026-08-31 and 2026-09-02. This is the largest set of purchases on record for this insider in LILA. Dip Buy: the stock was down in the previous period. The purchases were made through Grenadier S.A., indicating indirect ownership.
MSCI — Taneja Rajat bought $1.00M (largest purchase on record for this insider in MSCI). The transaction increased holdings by 49%.
Notable Buys
ATRA — Cherry Brian N purchased $1.00M (largest of 2 purchases in ATRA). This is the first recorded purchase for this insider, who now holds a significantly larger stake. The buy was made directly from the issuer via a sales agreement, not on the open market.
ENOV — Chief Executive Officer (McDonald Damien) bought $250K (first purchase of ENOV). Chief Administrative Officer (Engert Oliver) purchased $150K across 2 filings. Both insiders increased their stakes, with Engert's purchases representing his first and second buys in ENOV. The stock was up 5.6% over the period, and both insiders bought at prices near recent lows.
DGICA — Mutual Insurance Co Donegal purchased $382K across 2 filings (4th and 5th purchases in DGICA). This institutional insider has been a consistent buyer, with 4 other insiders also active in the last 30 days.
Notable Sells
ILMN — Meister Keith A. (indirect — See Footnotes) sold $61.6M across 9 filings between 2026-09-02 and 2026-09-04. These sales were made for the accounts of Corvex Funds, with Meister acting as investment adviser. The transactions represent a series of partial stake reductions, with a cumulative holding decrease of 11.4%. All sales were indirect and executed via multiple funds.
JNJ — EVP, WW Chair, MedTech (Schmid Timothy) sold $9.2M across 2 filings on 2026-09-02. These sales reduced his direct holdings by 47%. The transactions were executed at prices near recent highs.
NMIH — Chief Executive Officer (Pollitzer Adam) sold $7.75M on 2026-09-04, reducing his direct stake by 39%. This is a substantial sale for this insider.
PBF — Control Empresarial de Capitales S.A. de C.V. sold $7.7M across 2 filings on 2026-09-02. The sales were executed at prices near recent highs, with minimal change in overall holdings.
KRYS — President and CEO (Krishnan Krish S) and President, R&D (Krishnan Suma) sold a combined $13.7M across multiple filings on 2026-09-04. Both insiders executed a series of small, regular sales, each representing a minor reduction in their respective stakes. The transactions were clustered and executed at prices near all-time highs.
Patterns
- Healthcare and biotechnology insiders were active sellers, with over $90M in aggregate sales across ILMN, JNJ, NMIH, and KRYS.
- Communication services saw the largest insider buy, with nearly $10M purchased in LILA by an indirect owner.
- Multiple insiders at ENOV and DGICA increased their stakes, signaling coordinated buying in medical devices and insurance.
Close
Top buy tickers by $ value: LILA $9.98M, MSCI $1.00M, ATRA $1.00M.
Top sell tickers by $ value: ILMN $61.6M, JNJ $9.2M, NMIH $7.75M.